Debt-to-equity of SANGAMO THERAPEUTICS, INC from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SANGAMO THERAPEUTICS, INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • SANGAMO THERAPEUTICS, INC Debt-to-equity for the quarter ending 30 Sep 2025 was 599%, a 309% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 599% +452% +309% 30 Sep 2025
Q2 2025 359% +255% +247% 30 Jun 2025
Q1 2025 333% +268% +412% 31 Mar 2025
Q4 2024 206% +159% +345% 31 Dec 2024
Q3 2024 146% +91% +166% 30 Sep 2024
Q2 2024 104% +40% +62% 30 Jun 2024
Q1 2024 65% -11% -14% 31 Mar 2024
Q4 2023 46% -47% -50% 31 Dec 2023
Q3 2023 55% -39% -41% 30 Sep 2023
Q2 2023 64% -29% -31% 30 Jun 2023
Q1 2023 76% -15% -17% 31 Mar 2023
Q4 2022 93% +4.2% +4.7% 31 Dec 2022
Q3 2022 93% +5.3% +6% 30 Sep 2022
Q2 2022 93% +6% +6.9% 30 Jun 2022
Q1 2022 91% +7.4% +8.9% 31 Mar 2022
Q4 2021 89% +13% +18% 31 Dec 2021
Q3 2021 88% +23% +34% 30 Sep 2021
Q2 2021 87% +30% +53% 30 Jun 2021
Q1 2021 84% +34% +68% 31 Mar 2021
Q4 2020 76% +22% +42% 31 Dec 2020
Q3 2020 66% +8.9% +16% 30 Sep 2020
Q2 2020 57% -1.8% -3% 30 Jun 2020
Q1 2020 50% -12% -19% 31 Mar 2020
Q4 2019 53% -6.5% -11% 31 Dec 2019
Q3 2019 57% -1.6% -2.7% 30 Sep 2019
Q2 2019 59% +3.5% +6.4% 30 Jun 2019
Q1 2019 62% +13% +25% 31 Mar 2019
Q4 2018 60% +18% +42% 31 Dec 2018
Q3 2018 58% +25% +75% 30 Sep 2018
Q2 2018 55% +30% +116% 30 Jun 2018
Q1 2018 49% +34% +228% 31 Mar 2018
Q4 2017 42% +29% +220% 31 Dec 2017
Q3 2017 33% +21% +168% 30 Sep 2017
Q2 2017 26% +13% +103% 30 Jun 2017
Q1 2017 15% +1.9% +15% 31 Mar 2017
Q4 2016 13% -1.2% -8% 31 Dec 2016
Q3 2016 12% -3% -19% 30 Sep 2016
Q2 2016 13% -3.8% -23% 30 Jun 2016
Q1 2016 13% -3.8% -22% 31 Mar 2016
Q4 2015 14% -3.2% -18% 31 Dec 2015
Q3 2015 15% -1.7% -9.7% 30 Sep 2015
Q2 2015 16% +0.48% +3% 30 Jun 2015
Q1 2015 17% +0.41% +2.5% 31 Mar 2015
Q4 2014 17% +0.55% +3.2% 31 Dec 2014
Q3 2014 17% -2.4% -12% 30 Sep 2014
Q2 2014 16% -8.8% -36% 30 Jun 2014
Q1 2014 16% -7.6% -32% 31 Mar 2014
Q4 2013 17% -6.7% -28% 31 Dec 2013
Q3 2013 20% +0.71% +3.8% 30 Sep 2013
Q2 2013 25% 30 Jun 2013
Q1 2013 24% 31 Mar 2013
Q4 2012 24% 31 Dec 2012
Q3 2012 19% 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.